149 related articles for article (PubMed ID: 11918534)
1. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells.
Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V
Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534
[TBL] [Abstract][Full Text] [Related]
2. CD30L up-regulates CD30 and IL-4 expression by T cells.
Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V
FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464
[TBL] [Abstract][Full Text] [Related]
3. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.
Gattei V; Degan M; Rossi FM; de Iuliis A; Mazzocco FT; Serraino D; Zagonel V; Aldinucci D; Pinto A
Leuk Lymphoma; 1999 Sep; 35(1-2):21-35. PubMed ID: 10512160
[TBL] [Abstract][Full Text] [Related]
4. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
5. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
[TBL] [Abstract][Full Text] [Related]
6. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection.
Tang C; Yamada H; Shibata K; Muta H; Wajjwalku W; Podack ER; Yoshikai Y
J Immunol; 2008 Nov; 181(9):6316-27. PubMed ID: 18941223
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.
Ruggeri RM; Villari D; Simone A; Scarfi R; Attard M; Orlandi F; Barresi G; Trimarchi F; Trovato M; Benvenga S
J Endocrinol Invest; 2002 Dec; 25(11):959-66. PubMed ID: 12553555
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
[TBL] [Abstract][Full Text] [Related]
10. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals.
Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S
Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand.
Willers J; Dummer R; Kempf W; Kündig T; Burg G; Kadin ME
Clin Cancer Res; 2003 Jul; 9(7):2744-54. PubMed ID: 12855655
[TBL] [Abstract][Full Text] [Related]
12. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
Br J Haematol; 2001 Sep; 114(3):616-23. PubMed ID: 11552987
[TBL] [Abstract][Full Text] [Related]
13. Association of CD30 transcripts with Th1 responses and proinflammatory cytokines in patients with end-stage renal disease.
Velásquez SY; Opelz G; Rojas M; Süsal C; Alvarez CM
Hum Immunol; 2016 May; 77(5):403-10. PubMed ID: 26970513
[TBL] [Abstract][Full Text] [Related]
14. Regulation of murine B cell growth and differentiation by CD30 ligand.
Shanebeck KD; Maliszewski CR; Kennedy MK; Picha KS; Smith CA; Goodwin RG; Grabstein KH
Eur J Immunol; 1995 Aug; 25(8):2147-53. PubMed ID: 7664777
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors.
Iwata M; Eshima Y; Kagechika H
Int Immunol; 2003 Aug; 15(8):1017-25. PubMed ID: 12882839
[TBL] [Abstract][Full Text] [Related]
16. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression.
Kim MY; Anderson G; White A; Jenkinson E; Arlt W; Martensson IL; Erlandsson L; Lane PJ
J Immunol; 2005 Jun; 174(11):6686-91. PubMed ID: 15905508
[TBL] [Abstract][Full Text] [Related]
17. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression.
Mori M; Manuelli C; Pimpinelli N; Mavilia C; Maggi E; Santucci M; Bianchi B; Cappugi P; Giannotti B; Kadin ME
Blood; 1999 Nov; 94(9):3077-83. PubMed ID: 10556192
[TBL] [Abstract][Full Text] [Related]
18. In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.
Orleans-Lindsay JK; Deru A; Craig JI; Prentice HG; Lowdell MW
Clin Exp Immunol; 2003 Sep; 133(3):467-75. PubMed ID: 12930376
[TBL] [Abstract][Full Text] [Related]
19. Reverse signaling via CD30 ligand.
Wiley SR; Goodwin RG; Smith CA
J Immunol; 1996 Oct; 157(8):3635-9. PubMed ID: 8871664
[TBL] [Abstract][Full Text] [Related]
20. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
